DOV KADMON to Lung Neoplasms
This is a "connection" page, showing publications DOV KADMON has written about Lung Neoplasms.
Connection Strength
0.162
-
Solitary pulmonary metastasis from prostate cancer. J Urol. 1999 Dec; 162(6):2102.
Score: 0.078
-
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer. Cancer Gene Ther. 2007 Oct; 14(10):819-27.
Score: 0.033
-
Treatment of a metastatic prostate derived tumor with surgery and chemotherapy. J Urol. 1982 Jun; 127(6):1238-42.
Score: 0.023
-
Regression of metastatic renal cell carcinoma: a case report and literature review. J Urol. 1986 May; 135(5):1005-7.
Score: 0.008
-
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer. Oncologist. 2002; 7(5):458-66.
Score: 0.006
-
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer. Mol Ther. 2001 Apr; 3(4):500-6.
Score: 0.005
-
Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumor. Prostate. 1981; 2(3):299-307.
Score: 0.005
-
Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane. Cancer Res. 1982 Apr; 42(4):1390-4.
Score: 0.001
-
Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor. Cancer Lett. 1981 Jul; 13(2):139-45.
Score: 0.001